METTL3 further mediates m6A modification of JAK1 mRNA, and the m6A-YTHDF1 axis ultimately promotes JAK1 protein translation and STAT3 phosphorylation, facilitating CRC immune evasion and tumor progression 47. The gene discussed is METTL3; the disease is neoplasm.